Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fraction 1 capsular antigen is a major virulence factor of Yersinia pestis, the bacterium responsible for bubonic, septicemic, and pneumonic plague [UniProt P0C1R7]. It is a proteinaceous capsule composed of polymerized Caf1 subunits that forms a protective layer around the bacterium, primarily expressed at 37 degrees Celsius to coincide with host entry [PubMed: 15273110]. Its primary biological role is to prevent phagocytosis by host macrophages and neutrophils, thereby facilitating the systemic spread of the pathogen [PubMed: 11113130]. Because of its high immunogenicity and essential role in pathogenesis, the F1 antigen is a central component of subunit vaccines, often paired with the V antigen in the rF1-V fusion protein [PubMed: 21640134]. Additionally, it serves as a critical diagnostic marker for the rapid detection of plague and a target for therapeutic monoclonal antibodies designed to neutralize the bacteria during infection [PubMed: 17606508]. Therapeutic challenges include the potential emergence of F1-negative strains which can still cause disease while evading F1-targeted immunity [PubMed: 8654447].
Induction of neutralizing antibodies (vaccines); Neutralization of bacterial virulence and enhancement of opsonophagocytosis (monoclonal antibodies).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fraction 1 capsular antigen (F1).